Valneva annonce un accord exclusif avec CSL Seqirus pour le marketing et la distribution de ses vaccins en Allemagne Saint-Herblain, France, le 26 juin 2025 – (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui un accord exclusif avec CSL Seqirus, l'une des plus grandes entreprises de vaccins antigrippaux au monde, pour le marketing et la distribution des trois vaccins commerciaux de Valneva en Allemagne. Selon les termes de l'accord, CSL Seqirus commencera à commercialiser le vaccin unidose contre le chikungunya, IXCHIQ®, de Valneva à part...
Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus Saint-Herblain, France, June 26, 2025 – , (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companies, for the marketing and distribution of Valneva’s three proprietary vaccines in Germany. Under the agreed terms, CSL Seqirus will start commercializing Valneva’s single-dose chikungunya vaccine IXCHIQ® from July 2025, and Valneva’s Japanese Encephalitis vaccine IXIARO® and ...
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale annuelle et confirme ses perspectives financières 2025 Saint-Herblain (France), le 25 juin 2025 – (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par son conseil d’administration ont été approuvées par les actionnaires lors de son Assemblée Générale annuelle qui s'est tenue aujourd’hui à Lyon. Parmi les résolutions approuvées figuraient les comptes de l’exercice 2024, des délégations consenties au conseil d’administratio...
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance Saint-Herblain (France), June 25, 2025 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Annual General Meeting held today in Lyon, France. Among the adopted resolutions were the approval of the 2024 financial statements, delegations for the Board of Directors to increase Valneva’s share capital and/or issue financial instruments, the appointment of Dr. Gerd Z...
McPhy Energy : Procédure de redressement judiciaire et offres de reprise - Point de situation Foussemagne (France), le 25 juin 2025 – 17h45 CEST McPhy Energy (« McPhy ») annonce que, lors d’une audience en date du 24 juin 2025, le Tribunal de commerce de Belfort (le « Tribunal ») a examiné les offres de reprise déposées dans le cadre de la procédure de redressement judiciaire1. Le délibéré a été fixé au 8 juillet 2025. Qu’une offre de reprise soit adoptée ou non par le Tribunal, il est anticipé que le redressement judiciaire ouvert à l’égard de McPhy sera converti en liquidation judici...
McPhy Energy: Judicial reorganization and offers - Update Foussemagne (France), June 25, 2025 – 5.45 p.m. CEST McPhy Energy (“McPhy”) announces that, during the hearing on June 24, 2025, the Belfort Commercial Court (the “Court”) reviewed the offers submitted as part of the judicial reorganization process1. The deliberation has been set for July 8, 2025. Whether or not an offer is adopted by the Court, it is anticipated that the judicial reorganization opened against McPhy will be converted into judicial liquidation to allow the liquidation of the assets and activities not transferred. ...
A director at Nanobiotix bought 11,000 shares at 5.622USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Feedback of the companies present at the ODDO BHF Nextcap Forum Company Country Market cap. (m) Company Country Market cap. (m) Accsys Technologies € 124 Hoffmann Green € 62 Afyren € 72 Hornbach € 1 451 Altri € 1 058 IDI € 537 AMG € 550 Implenia CHF 973 AmRest PLN 3 544 Jacquet Metals € 494 Arcure € 29 Kloeckner & Co € 653 Arverne 194 Knaustabbert € 144 Austriacard Holdings € 188 Lna Santé € 270 Bastide € 218 Medincell € 398 Befesa € 1 116 Nacon € 63 CAF € 1 649 N...
Our 14th edition of the ODDO BHF Nextcap Forum took place on 11 June in Paris, and on 12 June virtually. 96 companies and 170 investors were present for more than 700 meetings organized. Overall, we noted a still cautious tone from companies, with limited visibility on a solid rebound in a persistently uncertain market environment (geopolitical situation, US politics, etc.), even if there are some signs of recovery and certain sectors remain very well positioned (leisure, energy, defence). At th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.